Leukemia is the most common childhood cancer, and while most patients are cured with standard therapy, those with refractory disease face dire outcomes. The development of a treatment called CAR T cell therapy changed this dramatically; today, more than 80% of children with resistant leukemias achieve complete remission after a single infusion of these engineered immune cells. This is one of the most remarkable advances in the history of cancer.
Fighting childhood cancer, one cup at a time.
